GSK has announced it will merge its consumer healthcare unit with Pfizer in a giant deal to create a new business with almost £10bn in annual sales.
GSK will have a majority share of the venture (68%). – image courtesy of Depositphotos. The UK pharmaceutical firm – behind household brands including Aquafresh toothpaste, Panadol and Beechams – will have a majority share of the new venture (68%). According to GSK, the deal is set to deliver cost savings…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login

